Not just Holistic, but how to use E: All of the Above!

I made this blog because I did tons of research on success stories and research worldwide and used it on my dog with nasal cancer named Lucy. So, now my hobby is molecular biology. The treatment uses combination of health store supplements, some prescription meds, diet changes, and specific Ayurvedic and Chinese medicinal herbs. I just wanted her to have a better quality of life. I thought this combination of E: All the Above (except no radiation or chemo and surgery for this cancer was not an option) would help that for sure, but it actually put her bleeding nasal cancer in remission!
My approach to cancer is about treating the whole animals biologic system. But I do hate the word 'Holistic'. Sounds like hoo hoo. This is science based, research based data and results of using active herbal compounds that happen to be readily available and common. Some call it Nutriceuticals. Others may call it Orthomolecular cancer therapy. Or Cancer Immunotherapy.
I FEEL DIVERSITY IN TREATMENT IS KEY:
-Slow cancer cell reproduction
-Make cancer cells become easier targets for the immune system
-Kill the cancer cells
-Rid the cancer cells
-Remove the toxins it produces
- Stimulate and Modulate the immune system
-Control secondary symptoms like bleeding, infection, inflammation, mucous, appetite, or pain for a better feeling animal
-Working with your vet for exams and prescriptions that are sometimes needed when conditions are acute.
Just by using a multi-modal treatment approach that is as diverse in attack as possible. Both conventional and natural.
The body conditions that allowed it to develop in the first place must be corrected. If caught early enough, like with Lucy, this ongoing maintenance correctional treatment is all that was required at this point to achieve, so far, more than 10 TIMES the life expectancy given (more than 60 months) after diagnosis WITH remission. I did not use radiation or chemotherapy or surgery.
I hope this cancer research can help your dog as well.

My Lucy

My Lucy
In Loving Memory my Lucy December 2016
CURRENT STATUS - It was for more than 5 YEARS after Lucy was diagnosed by biopsy in March 2011 with nasal cancer that she lived. And she was in remission for 4 of 5 years using no radiation or chemo! Now multiply that by 7 to be 35 years extended!! She was 12.5 years old - equivalent to almost 90 human years old. She ended her watch December 1, 2016. I miss her so much.

July 16, 2012

Low Dose Naltrexone in the treatment of dogs, cats, horses and other pets


Information on the use of Low Dose Naltrexone in the treatment of dogs, cats, horses and other pets. Known by the acronym LDN, this is a "low dose" form of therapy utilizing the FDA approved drug Naltrexone for the "off label" treatment of immune related disorders. The mechanism of action appears to involve an immune modulating or balancing effect of various components of the immune system mediated through an effect on Endorphin levels.

Naltrexone was approved by the FDA in 1984. It is legally available to be prescribed by physicians and veterinarians for any purpose. When given to humans in low doses, Naltrexone increases the body's production of endorphins. Endorphins are hormones, produced by the body, which help maintain and regulate the immune system. There is a growing body of information reporting the effectivness of LDN in the treatment of a wide range of immune related and auto-immune disorders. It has been in use in this manner for over 20 years.



LDN Has Virtually No Side Effects:

Occasionally, during the first week's use of LDN, patients may have some difficulty sleeping. This rarely persists after the first week. Should it do so, dosage can be temporarily reduced from 4.5mg to 3mg nightly for humans or for most dogs from 3mg to 2mg. Remember regular dosages are 50mg and up. So this really is LOW DOSE Naltrexone usage.

In developing Naltrexone for full dose use toxicity testing in rats, rabbits, dogs and monkeys determined that at therapeutic levels Naltrexone was non-toxic and had very few side effects. However obtaining FDA approval for the Low Dose regimen will require funding that due to the present out of patent or generic status of the drug will be difficult to obtain from any pharmaceutical company. Some privately funded pilot studies have been conducted and show much promise. More extensive studies are needed and funding continues to be sought by advocates of LDN.
Posted by Unknown at 4:14 PM
Labels: , ,